Hepatitis C remains major problem for HIV patients despite antiretroviral therapy

Patients with both HIV and hepatitis C had 80 percent higher rates of serious liver disease than hepatitis C patients

2014-03-17

(Press-News.org) PHILADELPHIA—A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that the risk of hepatitis C-associated serious liver disease persists in HIV patients otherwise benefitting from antiretroviral therapy (ART) to treat HIV.

It has been suggested that ART slows hepatitis C-associated liver fibrosis; however, whether rates of severe liver complications in patients co-infected with HIV and hepatitis C receiving ART were similar to those with just hepatitis C remained unclear.

The study, published in the March 18 issue of Annals of Internal Medicine, examined electronic medical record data of 4,280 patients infected with both HIV and chronic hepatitis C virus who were receiving ART, and 6,079 hepatitis C-only patients receiving care between 1997 and 2010.

It found that the HIV/hepatitis C-co-infected patients had an 80 percent higher rate of decompensated cirrhosis than hepatitis C-only patients. Even when co-infected patients had controlled HIV virus in response to ART, they still had a 60 percent higher rate of serious liver disease compared to those with hepatitis C alone.

"Our results suggest that serious consideration should be given to initiating hepatitis C treatment in patients co-infected with HIV and hepatitis C—particularly among those with advanced liver fibrosis or cirrhosis—in order to try to reduce the risk of serious, potentially life-threatening liver complications," said the study's lead author, Vincent Lo Re III, MD, MSCE, assistant professor of Medicine and Epidemiology in the division of Infectious Diseases and department of Biostatistics and Epidemiology at Penn, and an investigator in the Penn Center for AIDS Research. "By taking action sooner, we may be able to reduce the risk of advanced liver disease in co-infected patients."

This Penn-led study is the largest comparison to date of liver-related complications between antiretroviral-treated HIV/hepatitis C- co-infected patients and those with hepatitis C-alone.

Hepatitis C is a treacherous infection of the liver that can remain clinically dormant for years. The U.S. Centers for Disease Control and Prevention has reported that hepatitis C is the leading cause of cirrhosis, liver cancer, and the need for liver transplants in the nation. It is spread through contact with infected blood. Health experts estimate that more Americans die from it each year than HIV. Co-infection with hepatitis C occurs in 20-30 percent of patients with HIV infection, likely due to a shared route of infection.

Liver disease usually occurs in two stages: compensated and decompensated. In the earlier, less severe stage, the liver still can function normally by compensating for the damage. When extensive damage occurs and the liver can no longer function normally, decompensation occurs. The higher rates of serious liver disease found in co-infected patients in the Penn-led study were classified as liver decompensation.

The authors also found that rates of decompensation were higher for co-infected patients with advanced liver fibrosis, severe anemia, diabetes, and non-black race.

INFORMATION: In addition to Dr. Lo Re, other Penn co-authors include Michael J. Kallan, MS; A. Russell Localio, PhD; K. Rajender Reddy, MD; and Jay R. Kostman, MD. Brian L. Strom MD, MPH, formerly Executive Vice Dean for Institutional Affairs at Penn and now Chancellor of Rutgers Biomedical and Health Sciences, also participated in the investigation.

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Closer to detecting preeclampsia

2014-03-17

Identifying biomarkers could lead to earlier detection of preeclampsia, which in turn can lead to healthier mothers and children, according to a collaborative study from the Centre of Molecular Inflammation Research (CEMIR) and the MR Cancer Group at the Norwegian University of Science and Technology (NTNU). Their findings, "Metabolomic Biomarkers in Serum and Urine in Women with Preeclampsia," will be published in PLOS ONE on 17 March. "We have found that the metabolism in women who experience preeclampsia is clearly different from women with normal pregnancies. The ...

New evidence raises questions about the link between fatty acids and heart disease

2014-03-17

A new study raises questions about current guidelines which generally restrict the consumption of saturated fats and encourage consumption of polyunsaturated fats to prevent heart disease. The research was published today, 18 March, in the journal Annals of Internal Medicine. An international research collaboration led by the University of Cambridge analysed existing cohort studies and randomised trials on coronary risk and fatty acid intake. They showed that current evidence does not support guidelines which restrict the consumption of saturated fats in order to prevent ...

Knowing whether food has spoiled without even opening the container (video)

2014-03-17

DALLAS, March 17, 2014 — A color-coded smart tag could tell consumers whether a carton of milk has turned sour or a can of green beans has spoiled without opening the containers, according to researchers. The tag, which would appear on the packaging, also could be used to determine if medications and other perishable products were still active or fresh, they said. This report on the color-changing food deterioration tags was presented today as part of the 247th National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society. ...

Better continuity of care for elderly pataients cuts costs and complications, study finds

2014-03-17

Improving the coordination of care for elderly patients with chronic diseases trims costs, reduces use of health services and cuts complications, according to a new RAND Corporation study. Studying a large group of Medicare patients, researchers found that even modest improvements in the continuity of care among patients with diabetes, congestive heart failure or emphysema were associated with sizable reductions in use of hospital emergency departments and hospitalizations. The findings, published online by JAMA Internal Medicine, suggest that improving the coordination ...

US headache sufferers get $1 billion worth of brain scans each year, U-M study finds

2014-03-17

ANN ARBOR, Mich. — One in eight visits to a a doctor for a headache or migraine end up with the patient going for a brain scan, at a total cost of about $1 billion a year, a new University of Michigan Medical School study finds. And many of those MRI and CT scans – and costs – are probably unnecessary, given the very low odds that serious issues lurk in the patients' brains. In fact, several national guidelines for doctors specifically discourage scanning the brains of patients who complain of headache and migraine. But the new study shows the rate of brain scans for ...

Rocky Mountain wildflower season lengthens by more than a month

2014-03-17

A unique 39-year study of wildflower blooms in a Colorado Rocky Mountain meadow shows more than two-thirds of alpine flowers have changed their blooming pattern in response to climate change. Not only are half the flowers beginning to bloom weeks earlier, but more than a third are reaching their peak bloom earlier, and others are producing their last blooms later in the year. The bloom season, which used to run from late May to early September, now lasts from late April to late September, according to University of Maryland Biology Professor David Inouye. The wildflower ...

U-M scientists slow development of Alzheimer's trademark cell-killing plaques

2014-03-17

ANN ARBOR—University of Michigan researchers have learned how to fix a cellular structure called the Golgi that mysteriously becomes fragmented in all Alzheimer's patients and appears to be a major cause of the disease. They say that understanding this mechanism helps decode amyloid plaque formation in the brains of Alzheimer's patients—plaques that kills cells and contributes to memory loss and other Alzheimer's symptoms. The researchers discovered the molecular process behind Golgi fragmentation, and also developed two techniques to 'rescue' the Golgi structure. ...

Bacterial reporters that get the scoop

2014-03-17

It's a jungle in there. In the tightly woven ecosystem of the human gut, trillions of bacteria compete with each other on a daily basis while they sense and react to signals from the immune system, ingested food, and other bacteria. Problems arise when bad gut bugs overtake friendly ones, or when the immune system is thrown off balance, as in Crohn's disease, celiac disease, and colorectal cancer. Doctors have struggled to diagnose these conditions early and accurately. But now a new engineered strain of E. coli bacteria could deliver status updates from this complex ...

NIH scientists track evolution of a superbug

2014-03-17

Using genome sequencing, National Institutes of Health (NIH) scientists and their colleagues have tracked the evolution of the antibiotic-resistant bacterium Klebsiella pneumoniae sequence type 258 (ST258), an important agent of hospital-acquired infections. While researchers had previously thought that ST258 K. pneumoniae strains spread from a single ancestor, the NIH team showed that the strains arose from at least two different lineages. The investigators also found that the key difference between the two groups lies in the genes involved in production of the bacterium's ...

Stanford makes flexible carbon nanotube circuits more reliable and power efficient

2014-03-17

Engineers would love to create flexible electronic devices, such as e-readers that could be folded to fit into a pocket. One approach they are trying involves designing circuits based on electronic fibers, known as carbon nanotubes (CNTs), instead of rigid silicon chips. But reliability is essential. Most silicon chips are based on a type of circuit design that allows them to function flawlessly even when the device experiences power fluctuations. However, it is much more challenging to do so with CNT circuits. Now a team at Stanford has developed a process to create ...